These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 29535812)
1. Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models. Mihailidou C; Papakotoulas P; Papavassiliou AG; Karamouzis MV Oncotarget; 2018 Feb; 9(12):10360-10374. PubMed ID: 29535812 [TBL] [Abstract][Full Text] [Related]
2. Ciclopirox Olamine Exerts Tumor-Suppressor Effects Yin J; Che G; Jiang K; Zhou Z; Wu L; Xu M; Liu J; Yan S Front Oncol; 2022; 12():791916. PubMed ID: 35251970 [TBL] [Abstract][Full Text] [Related]
3. The antitumor activity of the fungicide ciclopirox. Zhou H; Shen T; Luo Y; Liu L; Chen W; Xu B; Han X; Pang J; Rivera CA; Huang S Int J Cancer; 2010 Nov; 127(10):2467-77. PubMed ID: 20225320 [TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen and nitrogen species are crucial for the antifungal activity of amorolfine and ciclopirox olamine against the dermatophyte Trichophyton interdigitale. Carmo PHF; Freitas GJC; Dornelas JCM; Almeida BCT; Baltazar LM; Ferreira GF; Peres NTA; Santos DA Med Mycol; 2022 Aug; 60(8):. PubMed ID: 35896502 [TBL] [Abstract][Full Text] [Related]
5. CPX Targeting DJ-1 Triggers ROS-induced Cell Death and Protective Autophagy in Colorectal Cancer. Zhou J; Zhang L; Wang M; Zhou L; Feng X; Yu L; Lan J; Gao W; Zhang C; Bu Y; Huang C; Zhang H; Lei Y Theranostics; 2019; 9(19):5577-5594. PubMed ID: 31534504 [No Abstract] [Full Text] [Related]
6. Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines. Wu J; Liu H; Zhang G; Gu L; Zhang Y; Gao J; Wei Y; Ma Z PLoS One; 2016; 11(8):e0161509. PubMed ID: 27551974 [TBL] [Abstract][Full Text] [Related]
7. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells. Eberhard Y; McDermott SP; Wang X; Gronda M; Venugopal A; Wood TE; Hurren R; Datti A; Batey RA; Wrana J; Antholine WE; Dick JE; Schimmer AD Blood; 2009 Oct; 114(14):3064-73. PubMed ID: 19589922 [TBL] [Abstract][Full Text] [Related]
8. Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo. DeRosier LC; Huang ZQ; Sellers JC; Buchsbaum DJ; Vickers SM J Gastrointest Surg; 2006 Nov; 10(9):1291-300; discussion 1300. PubMed ID: 17114015 [TBL] [Abstract][Full Text] [Related]
9. The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer. Morgan MA; Parsels LA; Kollar LE; Normolle DP; Maybaum J; Lawrence TS Clin Cancer Res; 2008 Aug; 14(16):5142-9. PubMed ID: 18698032 [TBL] [Abstract][Full Text] [Related]
10. Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway. Zhou H; Shen T; Shang C; Luo Y; Liu L; Yan J; Li Y; Huang S Oncotarget; 2014 Oct; 5(20):10140-50. PubMed ID: 25294812 [TBL] [Abstract][Full Text] [Related]
11. Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteome. Dihazi GH; Bibi A; Jahn O; Nolte J; Mueller GA; Engel W; Dihazi H World J Stem Cells; 2013 Jan; 5(1):9-25. PubMed ID: 23362436 [TBL] [Abstract][Full Text] [Related]
12. Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein. Karikari CA; Roy I; Tryggestad E; Feldmann G; Pinilla C; Welsh K; Reed JC; Armour EP; Wong J; Herman J; Rakheja D; Maitra A Mol Cancer Ther; 2007 Mar; 6(3):957-66. PubMed ID: 17339366 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancer. Sun JD; Liu Q; Ahluwalia D; Li W; Meng F; Wang Y; Bhupathi D; Ruprell AS; Hart CP Cancer Biol Ther; 2015; 16(3):438-49. PubMed ID: 25679067 [TBL] [Abstract][Full Text] [Related]
14. Ciclopirox Olamine Induces Proliferation Inhibition and Protective Autophagy in Hepatocellular Carcinoma. Wan X; Xiang J; Fan H; Jiang Y; Lu Y; Zhang C; Zhang Y; Chen Q; Lei Y Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678610 [TBL] [Abstract][Full Text] [Related]
15. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK. Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756 [TBL] [Abstract][Full Text] [Related]
16. Ciclopirox targets cellular bioenergetics and activates ER stress to induce apoptosis in non-small cell lung cancer cells. Lu J; Li Y; Gong S; Wang J; Lu X; Jin Q; Lu B; Chen Q Cell Commun Signal; 2022 Mar; 20(1):37. PubMed ID: 35331268 [TBL] [Abstract][Full Text] [Related]
17. Retraction: Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models. Mihailidou C; Papakotoulas P; Papavassiliou AG; Karamouzis MV Oncotarget; 2024 Jul; 15():461. PubMed ID: 38985135 [No Abstract] [Full Text] [Related]
18. ROS generation attenuates the anti-cancer effect of CPX on cervical cancer cells by inducing autophagy and inhibiting glycophagy. Fan H; He Y; Xiang J; Zhou J; Wan X; You J; Du K; Li Y; Cui L; Wang Y; Zhang C; Bu Y; Lei Y Redox Biol; 2022 Jul; 53():102339. PubMed ID: 35636017 [TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma. Zagon IS; Jaglowski JR; Verderame MF; Smith JP; Leure-Dupree AE; McLaughlin PJ Cancer Chemother Pharmacol; 2005 Nov; 56(5):510-20. PubMed ID: 15947928 [TBL] [Abstract][Full Text] [Related]
20. Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex. Weir SJ; Dandawate P; Standing D; Bhattacharyya S; Ramamoorthy P; Rangarajan P; Wood R; Brinker AE; Woolbright BL; Tanol M; Ham T; McCulloch W; Dalton M; Reed GA; Baltezor MJ; Jensen RA; Taylor JA; Anant S Cell Death Dis; 2021 May; 12(6):562. PubMed ID: 34059639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]